Shattuck Labs is conducting an underwritten public offering of 10.9 million common shares and 7.9 million pre-funded warrants with representatives including Leerink Partners, J.P. Morgan Securities, Piper Sandler, and Cantor Fitzgerald. The offering is expected to raise capital for the biotech company's operations and development efforts.